In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a vasopeptidase inhibitor, BMS189921.

被引：0
|
作者：
Burrell, L
Hubner, R
Powell, J
Johnston, C
机构：
[1] Univ Melbourne, Austin & Repat Med Ctr, Heidelberg, Vic, Australia
[2] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome
    Eizenberg, Yoav
    Grossman, Ehud
    Peleg, Edna
    Shabtai, Zehava
    Sharabi, Yehonatan
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (04) : 227 - 231
  • [22] Role of neutral endopeptidase and angiotensin converting enzyme in asthma
    Dusser, DJ
    PEDIATRIC PULMONOLOGY, 1999, : 103 - 104
  • [23] Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats
    Daull, P
    Blouin, A
    Sirois, P
    Nantel, F
    Jeng, AY
    Battistini, B
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 : S398 - S401
  • [24] CGS 30440: A dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11
    Cohen, DS
    Fink, CA
    Trapani, AJ
    Webb, RL
    Zane, PA
    Chatelain, RE
    CARDIOVASCULAR DRUG REVIEWS, 1999, 17 (01): : 16 - 38
  • [25] INHIBITION OF BOTH ANGIOTENSIN I-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE BY PEPTIDE THIOLS
    GIROUX, E
    BEACH, D
    BEIGHT, D
    FLYNN, G
    KOEHL, J
    MEHDL, S
    FASEB JOURNAL, 1993, 7 (07): : A1183 - A1183
  • [26] INHIBITION OF EITHER ANGIOTENSIN-CONVERTING ENZYME OR NEUTRAL ENDOPEPTIDASE INDUCES BOTH ENZYMES
    HELIN, K
    TIKKANEN, I
    HOHENTHAL, U
    FYHRQUIST, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (02) : 135 - 141
  • [27] Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by tricyclic benzazepinone thiols
    DeLombaert, S
    Beil, M
    Berry, C
    Blanchard, L
    Bohacek, R
    Chatelain, R
    Gerlock, T
    Ghai, RD
    Odorico, L
    Sakane, Y
    Stamford, LB
    Trapani, AJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 12 - MEDI
  • [28] Mechanism of vasopeptidase inhibitor-induced plasma extravasation: Comparison of omapatrilat and the novel neutral endopeptidase 24.11/angiotensin-converting enzyme inhibitor GW796406
    Sulpizio, AC
    Pullen, MA
    Edwards, RM
    Louttit, JB
    West, R
    Brooks, DP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1306 - 1313
  • [29] Dual neutral endopeptidase/angiotensin converting enzyme inhibition in rats with hypertension and diabetes mellitus
    Tikkanen, T
    Tikkanen, I
    Rockell, M
    Johnston, CI
    Cooper, ME
    Burrell, LM
    JOURNAL OF HYPERTENSION, 1998, 16 : S132 - S132
  • [30] Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension
    Wallis, EJ
    Ramsay, LE
    Hettiarachchi, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (04) : 439 - 449
12345